Find uplifting stories about heroes, innovations, and solutions
7875 results for "multiple myeloma"
A groundbreaking clinical trial shows 83% of multiple myeloma patients remained cancer-free for three years using a two-drug immunotherapy combination. The FDA fast-tracked approval in just four months, offering real hope that this once-incurable cancer may now be curable for most patients.
Cancer researchers are celebrating a major win in the fight against multiple myeloma as death rates decline thanks to breakthrough targeted therapies. Patients diagnosed with this once-deadly blood cancer now have more reasons for hope than ever before.
Artificial intelligence can now analyze routine bone marrow slides to predict which multiple myeloma patients need aggressive treatment and which can safely choose gentler options. The breakthrough could transform how doctors personalize cancer care.
A groundbreaking combination therapy for relapsed multiple myeloma has shown remarkable results, cutting the risk of cancer progression in half. This new treatment option brings fresh hope to patients facing one of blood cancer's toughest challenges.
Scientists have developed an AI system that reads bone marrow slides to match multiple myeloma patients with the treatments most likely to work for them. The breakthrough could help doctors personalize cancer care and spare patients from harsh therapies they don't need.
A breakthrough oral medication helped multiple myeloma patients live 18 months without their cancer worsening, more than double the time compared to standard treatment. The results offer fresh hope for thousands of people whose cancer has stopped responding to other therapies.
A newly approved combination therapy is giving people with hard-to-treat multiple myeloma real hope, with over 80% of patients still alive three years after treatment. The FDA greenlit the two-injection approach after seeing results that far outpaced standard treatments.
Cancer patients with multiple myeloma can now track their treatment progress with a simple blood draw instead of painful bone marrow biopsies. This breakthrough makes monitoring minimal residual disease faster, easier, and less painful for thousands of patients.
Cancer patients fighting multiple myeloma can now skip painful bone marrow tests thanks to a breakthrough blood test available at 7,000 locations nationwide. The affordable new test detects lingering cancer cells just as accurately while costing far less than existing options.
A breakthrough immunotherapy combination helped eight in 10 multiple myeloma patients live two years without their cancer worsening, nearly doubling the success rate of standard treatment. The results from a global trial of over 860 patients offer renewed hope for families facing this difficult blood cancer.
A new immunotherapy combination is helping eight out of ten multiple myeloma patients live two years without their cancer getting worse, doubling the success rate of standard treatment. The international trial involving over 860 patients offers fresh hope for people fighting this challenging blood cancer.
Twenty people with smoldering multiple myeloma have zero detectable cancer cells after receiving an aggressive immunotherapy treatment. The results are so complete that researchers are cautiously using a word they usually avoid: cure.
A groundbreaking combination therapy for multiple myeloma just won FDA approval, nearly tripling survival rates compared to standard treatment. This could become the new standard of care for thousands of cancer patients facing relapse.
When Black and white multiple myeloma patients receive the same modern treatments, they survive at equal rates. A Cleveland Clinic study proves access to care, not biology, drives health disparities.
After beating multiple myeloma twice through clinical trials, Julie Cohen turned her battle into a mission. She now dedicates her life to coaching other cancer patients through their darkest moments.
A breakthrough immune therapy is transforming multiple myeloma from a disease that always returned into one where patients can reach long-term remission. More than 36,000 Americans diagnosed this year now have access to treatments once considered impossible.
A groundbreaking immunotherapy combination helped 8 in 10 multiple myeloma patients live two years without their cancer getting worse, compared to just 5 in 10 with standard treatment. The global trial involving over 860 patients offers renewed hope for those facing this difficult blood cancer.
A blood cancer treatment that works like a "Trojan horse" to destroy cells from within just received approval in New Zealand, offering hope to 2,500 patients with multiple myeloma. One patient who joined the trial says the drug gave her confidence to believe in her future again.
After nearly 12 years of chemotherapy for multiple myeloma, personal trainer Tony Newberne is cancer-free thanks to groundbreaking CAR-T therapy. Now he's urging others to advocate for their own health and explore all treatment options.
Scientists at Oak Ridge National Laboratory just solved one of 3D printing's biggest problems: how to print with multiple materials at once without switching equipment or sacrificing speed. Their new system could transform everything from airplane parts to bridge construction.
Showing 20 of 7875